Annamaria Colao to Insulin-Like Growth Factor I
This is a "connection" page, showing publications Annamaria Colao has written about Insulin-Like Growth Factor I.
Connection Strength
2.406
-
Acromegaly and Heart Failure. Heart Fail Clin. 2019 Jul; 15(3):399-408.
Score: 0.735
-
Beyond waist circumference in an adult male population of Southern Italy: Is there any role for subscapular skinfold thickness in the relationship between insulin-like growth factor-I system and metabolic parameters? J Endocrinol Invest. 2012 Nov; 35(10):925-9.
Score: 0.453
-
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age. J Endocrinol Invest. 2005 May; 28(5):440-8.
Score: 0.275
-
Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance. J Clin Endocrinol Metab. 2001 Apr; 86(4):1551-7.
Score: 0.207
-
Obesity and breast cancer in premenopausal women: Current evidence and future perspectives. Eur J Obstet Gynecol Reprod Biol. 2018 Nov; 230:217-221.
Score: 0.168
-
Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson's disease. PLoS One. 2017; 12(10):e0186508.
Score: 0.163
-
Cardiovascular alterations in adult GH deficiency. Best Pract Res Clin Endocrinol Metab. 2017 02; 31(1):25-34.
Score: 0.157
-
Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults. Eur J Endocrinol. 2007 Dec; 157(6):701-8.
Score: 0.082
-
Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituritary disease. J Endocrinol Invest. 2005 Mar; 28(3):247-52.
Score: 0.068
-
Prostatic hyperplasia: an unknown feature of acromegaly. J Clin Endocrinol Metab. 1998 Mar; 83(3):775-9.
Score: 0.042
-
A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues. Eur J Endocrinol. 2017 Apr; 176(4):421-431.
Score: 0.039
-
CV 205-502 treatment in therapy-resistant acromegalic patients. Eur J Endocrinol. 1995 May; 132(5):559-64.
Score: 0.009
-
[Cardiac effects of GH]. Minerva Endocrinol. 1993 Sep; 18(3 Suppl 1):69-75.
Score: 0.008